18 0 2 0 2 B-lower_bound
to 3 5 3 5 O
65 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
old 15 18 15 18 O
with 19 23 19 23 O
a 24 25 24 25 O
BMI 26 29 26 29 B-bmi
of 30 32 30 32 O
35 33 35 33 35 B-lower_bound
kg 36 38 36 38 I-lower_bound
/ 38 39 38 39 I-lower_bound
m2 39 41 39 41 I-lower_bound
or 42 44 42 44 O
greater 45 52 45 52 O
who 53 56 53 56 O
will 57 61 57 61 O
be 62 64 62 64 O
undergoing 65 75 65 75 O
bariatric 76 85 76 85 B-treatment
surgery 86 93 86 93 I-treatment
( 94 95 94 95 O
VSG 95 98 95 98 B-treatment
and 99 102 99 102 O
RYGB 103 107 103 107 B-treatment
) 107 108 107 108 O

Active 0 6 109 115 O
clinically 7 17 116 126 O
significant 18 29 127 138 O
bleeding 30 38 139 147 B-chronic_disease

Combined 0 8 148 156 O
P 9 10 157 158 B-treatment
- 10 11 158 159 I-treatment
glycoprotein 11 23 159 171 I-treatment
and 24 27 172 175 O
moderate 28 36 176 184 B-treatment
CYP 37 40 185 188 I-treatment
3A4 41 44 189 192 I-treatment
inhibitor 45 54 193 202 I-treatment

Creatinine 0 10 203 213 B-clinical_variable
> 11 12 214 215 O
1.5 13 16 216 219 B-lower_bound
mg 17 19 220 222 I-lower_bound
/ 19 20 222 223 I-lower_bound
dL 20 22 223 225 I-lower_bound

History 0 7 226 233 O
of 8 10 234 236 O
cancer 11 17 237 243 B-cancer
( 18 19 244 245 O
within 19 25 245 251 O
the 26 29 252 255 O
last 30 34 256 260 B-upper_bound
year 35 39 261 265 I-upper_bound
) 39 40 265 266 O

History 0 7 267 274 O
of 8 10 275 277 O
documented 11 21 278 288 O
clotting 22 30 289 297 B-chronic_disease
/ 30 31 297 298 I-chronic_disease
coagulation 31 42 298 309 I-chronic_disease
disorder 43 51 310 318 I-chronic_disease

History 0 7 319 326 O
of 8 10 327 329 O
hypersensitivity 11 27 330 346 O
reaction 28 36 347 355 O
to 37 39 356 358 O
apixaban 40 48 359 367 B-allergy_name

Inducers 0 8 368 376 O
of 9 11 377 379 O
p 12 13 380 381 B-treatment
- 13 14 381 382 I-treatment
glycoprotein 14 26 382 394 I-treatment

Men 0 3 395 398 B-gender

Participants 0 12 399 411 O
currently 13 22 412 421 O
receiving 23 32 422 431 O
any 33 36 432 435 O
type 37 41 436 440 O
of 42 44 441 443 O
anticoagulation 45 60 444 459 B-treatment
or 61 63 460 462 O
blood 64 69 463 468 B-treatment
thinning 70 78 469 477 I-treatment
medications 79 90 478 489 I-treatment
, 90 91 489 490 O
including 92 101 491 500 O
heparin 102 109 501 508 B-treatment
, 109 110 508 509 O
low 111 114 510 513 B-treatment
molecular 115 124 514 523 I-treatment
weight 125 131 524 530 I-treatment
heparins 132 140 531 539 I-treatment
, 140 141 539 540 O
Plavix 142 148 541 547 B-treatment
, 148 149 547 548 O
aspirin 150 157 549 556 B-treatment
, 157 158 556 557 O
NSAIDS 159 165 558 564 B-treatment

Strong 0 6 565 571 O
inducers 7 15 572 580 O
of 16 18 581 583 O
CYP 19 22 584 587 B-treatment
3A4 23 26 588 591 I-treatment

Women 0 5 592 597 B-gender
must 6 10 598 602 O
not 11 14 603 606 O
be 15 17 607 609 O
breastfeeding 18 31 610 623 O

Women 0 5 624 629 B-gender
of 6 8 630 632 O
childbearing 9 21 633 645 O
potential 22 31 646 655 O
( 32 33 656 657 O
WOCBP 33 38 657 662 O
) 38 39 662 663 O
must 40 44 664 668 O
have 45 49 669 673 O
a 50 51 674 675 O
negative 52 60 676 684 B-pregnancy
serum 61 66 685 690 I-pregnancy
or 67 69 691 693 I-pregnancy
urine 70 75 694 699 I-pregnancy
pregnancy 76 85 700 709 I-pregnancy
test 86 90 710 714 O
( 91 92 715 716 O
minimum 92 99 716 723 O
sensitivity 100 111 724 735 O
25 112 114 736 738 B-lower_bound
IU 115 117 739 741 I-lower_bound
/ 117 118 741 742 I-lower_bound
L 118 119 742 743 I-lower_bound
or 120 122 744 746 O
equivalent 123 133 747 757 O
units 134 139 758 763 O
of 140 142 764 766 O
HCG 143 146 767 770 B-clinical_variable
) 146 147 770 771 O
within 148 154 772 778 O
24 155 157 779 781 B-upper_bound
hours 158 163 782 787 I-upper_bound
prior 164 169 788 793 I-upper_bound
to 170 172 794 796 O
the 173 176 797 800 O
start 177 182 801 806 O
of 183 185 807 809 O
study 186 191 810 815 O
drug 192 196 816 820 O

women 0 5 821 826 B-gender

